In The News
Pain Medicine News, with support from Johnson & Johnson Consumer Inc., has issued a Special Report on the role of OTC analgesics in acute pain management when considering opioid-sparing approaches, with contributions from healthcare professionals on the front lines. The Special Report, though not exhaustive, includes case studies, real-world clinical scenarios, a review of current guidelines, and efficacy and safety profiles of OTC pain relievers.
Growing interest in opioid-sparing pain management practices has given rise to multimodal regimens that use two or more pharmacologic (including Rx and OTC analgesics) and nonpharmacologic options for optimal pain management. According to the Pain Medicine News Special Report, addressing patient misperceptions about OTC analgesic efficacy and safety considerations can be an important first step in developing a written multimodal pain management plan with patients.
Multimodal Pain Management Planning Tools
The US Food and Drug Administration (FDA) recently required an update to the Drug Facts labeling of all adult, children’s, and infants’ non-aspirin over-the-counter (OTC) nonsteroidal anti-inflammatory drugs (NSAIDs), for example, Motrin®, Advil®, and Aleve® products.
These changes strengthen and expand existing warnings relating to the risk of heart attack and stroke associated with NSAIDs.
Download an NSAID label comparison illustrating these changes to aid in discussions with your patients.
A recent survey1 conducted by the US Pain Foundation, with support from Johnson & Johnson Consumer Inc., found that 97% of Americans feel confident when choosing which type of over-the-counter (OTC) pain medicines to take. However, the survey also revealed that many consumers disregard critical safety factors—such as their age, health conditions, and other medicines they are currently taking—when choosing an OTC pain reliever.
March 6, 2017
Study, resources on OTC Pain Relievers
– The American Nurse